Table 1.
Demographic Characteristics of the Per-Protocol Vaccine Recipient Cohorts from HVTN 097, HVTN 100, RV144 Subset, and the Female Per-Protocol Noncases in the HVTN 702 Case-Control Set for Immunogenicity Analyses
| Characteristic | HVTN 097 (n = 73) | HVTN 100 (n = 184) | RV144 (n = 201) | HVTN 702 (n = 60) |
|---|---|---|---|---|
| Planned treatment | ||||
| Placebo | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| Vaccine | 73 (100) | 184 (100) | 201 (100) | 60 (100) |
| Age in years at randomization | ||||
| Mean (SD) | 23 (4) | 24 (5) | … | 24 (4) |
| Range | 18–35 | 18–40 | … | 18–35 |
| Age category at randomization | ||||
| ≤20 | 27 (37) | 44 (24) | 56 (28) | 10 (17) |
| 21–25 | 17 (23) | 78 (42) | 97 (48) | 35 (58) |
| ≥26 | 29 (40) | 62 (34) | 48 (24) | 15 (25) |
| Sex assigned at birth | ||||
| Female | 33 (45) | 73 (40) | 79 (39) | 60 (100) |
| Male | 40 (55) | 111 (60) | 122 (61) | 0 (0) |
| BMI | ||||
| Mean (SD) | 23 (5) | 24 (5) | … | 27 (7) |
| Range | 17–37 | 16–39 | … | 17–47 |
| Region of enrollment | ||||
| Thailand | 0 (0) | 0 (0) | 201 (100) | 0 (0) |
| Central South Africa | 50 (68) | 100 (54) | 0 (0) | 34 (57) |
| KwaZulu-Natal South Africa | 0 (0) | 59 (32) | 0 (0) | 19 (32) |
| WestEast Cape South Africa | 23 (32) | 25 (14) | 0 (0) | 7 (12) |
| Education | ||||
| High school | 0 (0) | 135 (73) | 0 (0) | 55 (92) |
| Primary school | 0 (0) | 6 (3) | 0 (0) | 0 (0) |
| Tertiary college university | 0 (0) | 43 (23) | 0 (0) | 5 (8) |
| Prefer not to answer | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| Not available | 73 (100) | … | 201 (0) | … |
Data are No. (%) except where indicated.
Abbreviation: BMI, body mass index.